Intensity Therapeutics, Inc.
INTS
$3.67
-$0.07-1.87%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -3.05M | -2.67M | -2.54M | -3.35M | -3.18M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 457.00K | 477.00K | 651.00K | 441.00K | 876.00K |
| Change in Net Operating Assets | 193.00K | -193.00K | -570.00K | 917.00K | -363.00K |
| Cash from Operations | -2.40M | -2.39M | -2.46M | -1.99M | -2.67M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Investing | -- | -- | -- | -- | 0.00 |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 7.82M | 7.54M | 4.68M | 345.00K | 3.05M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -565.00K | -301.00K | -933.00K | -17.00K | -571.00K |
| Cash from Financing | 7.26M | 7.24M | 3.74M | 328.00K | 2.48M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.85M | 4.85M | 1.29M | -1.66M | -192.00K |